2018-2023 Global PEGylated Proteins Consumption Market Report

Publisher Name :
Date: 15-Jun-2018
No. of pages: 138

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023.

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor's products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.

Over the next five years, LPI(LP Information) projects that PEGylated Proteins will register a 3.9% CAGR in terms of revenue, reach US$ 3910 million by 2023, from US$ 3230 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of PEGylated Proteins market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Colony Stimulating Factors

- Interferons

- Erythropoietin (EPO)

- Recombinant Factor Viii

- Monoclonal Antibodies

- Others

Segmentation by application:

- Cancer Treatment

- Hepatitis

- Chronic Kidney Disease

- Leukemia

- SCID

- Rheumatoid Arthritis & Crohn's Disease

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- ENZON Pharmaceuticals

- Merck Sharp & Dohme

- Roche

- Pfizer

- Amgen

- UCB

- Crealta (Savient)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global PEGylated Proteins consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of PEGylated Proteins market by identifying its various subsegments.

- Focuses on the key global PEGylated Proteins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the PEGylated Proteins with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of PEGylated Proteins submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global PEGylated Proteins Consumption Market Report

Table of Contents

2018-2023 Global PEGylated Proteins Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PEGylated Proteins Consumption 2013-2023
2.1.2 PEGylated Proteins Consumption CAGR by Region
2.2 PEGylated Proteins Segment by Type
2.2.1 Colony Stimulating Factors
2.2.2 Interferons
2.2.3 Erythropoietin (EPO)
2.2.4 Recombinant Factor Viii
2.2.5 Monoclonal Antibodies
2.2.6 Others
2.3 PEGylated Proteins Consumption by Type
2.3.1 Global PEGylated Proteins Consumption Market Share by Type (2013-2018)
2.3.2 Global PEGylated Proteins Revenue and Market Share by Type (2013-2018)
2.3.3 Global PEGylated Proteins Sale Price by Type (2013-2018)
2.4 PEGylated Proteins Segment by Application
2.4.1 Cancer Treatment
2.4.2 Hepatitis
2.4.3 Chronic Kidney Disease
2.4.4 Leukemia
2.4.5 SCID
2.4.6 Rheumatoid Arthritis & Crohn's Disease
2.4.7 Others
2.5 PEGylated Proteins Consumption by Application
2.5.1 Global PEGylated Proteins Consumption Market Share by Application (2013-2018)
2.5.2 Global PEGylated Proteins Value and Market Share by Application (2013-2018)
2.5.3 Global PEGylated Proteins Sale Price by Application (2013-2018)
3 Global PEGylated Proteins by Players
3.1 Global PEGylated Proteins Sales Market Share by Players
3.1.1 Global PEGylated Proteins Sales by Players (2016-2018)
3.1.2 Global PEGylated Proteins Sales Market Share by Players (2016-2018)
3.2 Global PEGylated Proteins Revenue Market Share by Players
3.2.1 Global PEGylated Proteins Revenue by Players (2016-2018)
3.2.2 Global PEGylated Proteins Revenue Market Share by Players (2016-2018)
3.3 Global PEGylated Proteins Sale Price by Players
3.4 Global PEGylated Proteins Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global PEGylated Proteins Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players PEGylated Proteins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 PEGylated Proteins by Regions
4.1 PEGylated Proteins by Regions
4.1.1 Global PEGylated Proteins Consumption by Regions
4.1.2 Global PEGylated Proteins Value by Regions
4.2 Americas PEGylated Proteins Consumption Growth
4.3 APAC PEGylated Proteins Consumption Growth
4.4 Europe PEGylated Proteins Consumption Growth
4.5 Middle East & Africa PEGylated Proteins Consumption Growth
5 Americas
5.1 Americas PEGylated Proteins Consumption by Countries
5.1.1 Americas PEGylated Proteins Consumption by Countries (2013-2018)
5.1.2 Americas PEGylated Proteins Value by Countries (2013-2018)
5.2 Americas PEGylated Proteins Consumption by Type
5.3 Americas PEGylated Proteins Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC PEGylated Proteins Consumption by Countries
6.1.1 APAC PEGylated Proteins Consumption by Countries (2013-2018)
6.1.2 APAC PEGylated Proteins Value by Countries (2013-2018)
6.2 APAC PEGylated Proteins Consumption by Type
6.3 APAC PEGylated Proteins Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe PEGylated Proteins by Countries
7.1.1 Europe PEGylated Proteins Consumption by Countries (2013-2018)
7.1.2 Europe PEGylated Proteins Value by Countries (2013-2018)
7.2 Europe PEGylated Proteins Consumption by Type
7.3 Europe PEGylated Proteins Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa PEGylated Proteins by Countries
8.1.1 Middle East & Africa PEGylated Proteins Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa PEGylated Proteins Value by Countries (2013-2018)
8.2 Middle East & Africa PEGylated Proteins Consumption by Type
8.3 Middle East & Africa PEGylated Proteins Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 PEGylated Proteins Distributors
10.3 PEGylated Proteins Customer
11 Global PEGylated Proteins Market Forecast
11.1 Global PEGylated Proteins Consumption Forecast (2018-2023)
11.2 Global PEGylated Proteins Forecast by Regions
11.2.1 Global PEGylated Proteins Forecast by Regions (2018-2023)
11.2.2 Global PEGylated Proteins Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global PEGylated Proteins Forecast by Type
11.8 Global PEGylated Proteins Forecast by Application
12 Key Players Analysis
12.1 ENZON Pharmaceuticals
12.1.1 Company Details
12.1.2 PEGylated Proteins Product Offered
12.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 ENZON Pharmaceuticals News
12.2 Merck Sharp & Dohme
12.2.1 Company Details
12.2.2 PEGylated Proteins Product Offered
12.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Merck Sharp & Dohme News
12.3 Roche
12.3.1 Company Details
12.3.2 PEGylated Proteins Product Offered
12.3.3 Roche PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Roche News
12.4 Pfizer
12.4.1 Company Details
12.4.2 PEGylated Proteins Product Offered
12.4.3 Pfizer PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 Amgen
12.5.1 Company Details
12.5.2 PEGylated Proteins Product Offered
12.5.3 Amgen PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Amgen News
12.6 UCB
12.6.1 Company Details
12.6.2 PEGylated Proteins Product Offered
12.6.3 UCB PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 UCB News
12.7 Crealta (Savient)
12.7.1 Company Details
12.7.2 PEGylated Proteins Product Offered
12.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Crealta (Savient) News
...
13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of PEGylated Proteins
Table Product Specifications of PEGylated Proteins
Figure PEGylated Proteins Report Years Considered
Figure Market Research Methodology
Figure Global PEGylated Proteins Consumption Growth Rate 2013-2023 (g)
Figure Global PEGylated Proteins Value Growth Rate 2013-2023 ($ Millions)
Table PEGylated Proteins Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Colony Stimulating Factors
Table Major Players of Colony Stimulating Factors
Figure Product Picture of Interferons
Table Major Players of Interferons
Figure Product Picture of Erythropoietin (EPO)
Table Major Players of Erythropoietin (EPO)
Figure Product Picture of Recombinant Factor Viii
Table Major Players of Recombinant Factor Viii
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global PEGylated Proteins Consumption Market Share by Type (2013-2018)
Figure Global PEGylated Proteins Consumption Market Share by Type (2013-2018)
Table Global PEGylated Proteins Revenue by Type (2013-2018) ($ million)
Table Global PEGylated Proteins Value Market Share by Type (2013-2018) ($ Millions)
Figure Global PEGylated Proteins Value Market Share by Type (2013-2018)
Table Global PEGylated Proteins Sale Price by Type (2013-2018)
Figure PEGylated Proteins Consumed in Cancer Treatment
Figure Global PEGylated Proteins Market: Cancer Treatment (2013-2018) (g)
Figure Global PEGylated Proteins Market: Cancer Treatment (2013-2018) ($ Millions)
Figure Global Cancer Treatment YoY Growth ($ Millions)
Figure PEGylated Proteins Consumed in Hepatitis
Figure Global PEGylated Proteins Market: Hepatitis (2013-2018) (g)
Figure Global PEGylated Proteins Market: Hepatitis (2013-2018) ($ Millions)
Figure Global Hepatitis YoY Growth ($ Millions)
Figure PEGylated Proteins Consumed in Chronic Kidney Disease
Figure Global PEGylated Proteins Market: Chronic Kidney Disease (2013-2018) (g)
Figure Global PEGylated Proteins Market: Chronic Kidney Disease (2013-2018) ($ Millions)
Figure Global Chronic Kidney Disease YoY Growth ($ Millions)
Figure PEGylated Proteins Consumed in Leukemia
Figure Global PEGylated Proteins Market: Leukemia (2013-2018) (g)
Figure Global PEGylated Proteins Market: Leukemia (2013-2018) ($ Millions)
Figure Global Leukemia YoY Growth ($ Millions)
Figure PEGylated Proteins Consumed in SCID
Figure Global PEGylated Proteins Market: SCID (2013-2018) (g)
Figure Global PEGylated Proteins Market: SCID (2013-2018) ($ Millions)
Figure Global SCID YoY Growth ($ Millions)
Figure PEGylated Proteins Consumed in Rheumatoid Arthritis & Crohn's Disease
Figure PEGylated Proteins Consumed in Others
Table Global Consumption Sales by Application (2013-2018)
Table Global PEGylated Proteins Consumption Market Share by Application (2013-2018)
Figure Global PEGylated Proteins Consumption Market Share by Application (2013-2018)
Table Global PEGylated Proteins Value by Application (2013-2018)
Table Global PEGylated Proteins Value Market Share by Application (2013-2018)
Figure Global PEGylated Proteins Value Market Share by Application (2013-2018)
Table Global PEGylated Proteins Sale Price by Application (2013-2018)
Table Global PEGylated Proteins Sales by Players (2016-2018) (g)
Table Global PEGylated Proteins Sales Market Share by Players (2016-2018)
Figure Global PEGylated Proteins Sales Market Share by Players in 2016
Figure Global PEGylated Proteins Sales Market Share by Players in 2017
Table Global PEGylated Proteins Revenue by Players (2016-2018) ($ Millions)
Table Global PEGylated Proteins Revenue Market Share by Players (2016-2018)
Figure Global PEGylated Proteins Revenue Market Share by Players in 2016
Figure Global PEGylated Proteins Revenue Market Share by Players in 2017
Table Global PEGylated Proteins Sale Price by Players (2016-2018)
Figure Global PEGylated Proteins Sale Price by Players in 2017
Table Global PEGylated Proteins Manufacturing Base Distribution and Sales Area by Players
Table Players PEGylated Proteins Products Offered
Table PEGylated Proteins Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global PEGylated Proteins Consumption by Regions 2013-2018 (g)
Table Global PEGylated Proteins Consumption Market Share by Regions 2013-2018
Figure Global PEGylated Proteins Consumption Market Share by Regions 2013-2018
Table Global PEGylated Proteins Value by Regions 2013-2018 ($ Millions)
Table Global PEGylated Proteins Value Market Share by Regions 2013-2018
Figure Global PEGylated Proteins Value Market Share by Regions 2013-2018
Figure Americas PEGylated Proteins Consumption 2013-2018 (g)
Figure Americas PEGylated Proteins Value 2013-2018 ($ Millions)
Figure APAC PEGylated Proteins Consumption 2013-2018 (g)
Figure APAC PEGylated Proteins Value 2013-2018 ($ Millions)
Figure Europe PEGylated Proteins Consumption 2013-2018 (g)
Figure Europe PEGylated Proteins Value 2013-2018 ($ Millions)
Figure Middle East & Africa PEGylated Proteins Consumption 2013-2018 (g)
Figure Middle East & Africa PEGylated Proteins Value 2013-2018 ($ Millions)
Table Americas PEGylated Proteins Consumption by Countries (2013-2018) (g)
Table Americas PEGylated Proteins Consumption Market Share by Countries (2013-2018)
Figure Americas PEGylated Proteins Consumption Market Share by Countries in 2017
Table Americas PEGylated Proteins Value by Countries (2013-2018) ($ Millions)
Table Americas PEGylated Proteins Value Market Share by Countries (2013-2018)
Figure Americas PEGylated Proteins Value Market Share by Countries in 2017
Table Americas PEGylated Proteins Consumption by Type (2013-2018) (g)
Table Americas PEGylated Proteins Consumption Market Share by Type (2013-2018)
Figure Americas PEGylated Proteins Consumption Market Share by Type in 2017
Table Americas PEGylated Proteins Consumption by Application (2013-2018) (g)
Table Americas PEGylated Proteins Consumption Market Share by Application (2013-2018)
Figure Americas PEGylated Proteins Consumption Market Share by Application in 2017
Figure United States PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure United States PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Canada PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Canada PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Mexico PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Mexico PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Table APAC PEGylated Proteins Consumption by Countries (2013-2018) (g)
Table APAC PEGylated Proteins Consumption Market Share by Countries (2013-2018)
Figure APAC PEGylated Proteins Consumption Market Share by Countries in 2017
Table APAC PEGylated Proteins Value by Countries (2013-2018) ($ Millions)
Table APAC PEGylated Proteins Value Market Share by Countries (2013-2018)
Figure APAC PEGylated Proteins Value Market Share by Countries in 2017
Table APAC PEGylated Proteins Consumption by Type (2013-2018) (g)
Table APAC PEGylated Proteins Consumption Market Share by Type (2013-2018)
Figure APAC PEGylated Proteins Consumption Market Share by Type in 2017
Table APAC PEGylated Proteins Consumption by Application (2013-2018) (g)
Table APAC PEGylated Proteins Consumption Market Share by Application (2013-2018)
Figure APAC PEGylated Proteins Consumption Market Share by Application in 2017
Figure China PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure China PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Japan PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Japan PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Korea PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Korea PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Southeast Asia PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure India PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure India PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Australia PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Australia PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Table Europe PEGylated Proteins Consumption by Countries (2013-2018) (g)
Table Europe PEGylated Proteins Consumption Market Share by Countries (2013-2018)
Figure Europe PEGylated Proteins Consumption Market Share by Countries in 2017
Table Europe PEGylated Proteins Value by Countries (2013-2018) ($ Millions)
Table Europe PEGylated Proteins Value Market Share by Countries (2013-2018)
Figure Europe PEGylated Proteins Value Market Share by Countries in 2017
Table Europe PEGylated Proteins Consumption by Type (2013-2018) (g)
Table Europe PEGylated Proteins Consumption Market Share by Type (2013-2018)
Figure Europe PEGylated Proteins Consumption Market Share by Type in 2017
Table Europe PEGylated Proteins Consumption by Application (2013-2018) (g)
Table Europe PEGylated Proteins Consumption Market Share by Application (2013-2018)
Figure Europe PEGylated Proteins Consumption Market Share by Application in 2017
Figure Germany PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Germany PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure France PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure France PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure UK PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure UK PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Italy PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Italy PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Russia PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Russia PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Spain PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Spain PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa PEGylated Proteins Consumption by Countries (2013-2018) (g)
Table Middle East & Africa PEGylated Proteins Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa PEGylated Proteins Consumption Market Share by Countries in 2017
Table Middle East & Africa PEGylated Proteins Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa PEGylated Proteins Value Market Share by Countries (2013-2018)
Figure Middle East & Africa PEGylated Proteins Value Market Share by Countries in 2017
Table Middle East & Africa PEGylated Proteins Consumption by Type (2013-2018) (g)
Table Middle East & Africa PEGylated Proteins Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa PEGylated Proteins Consumption Market Share by Type in 2017
Table Middle East & Africa PEGylated Proteins Consumption by Application (2013-2018) (g)
Table Middle East & Africa PEGylated Proteins Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa PEGylated Proteins Consumption Market Share by Application in 2017
Figure Egypt PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Egypt PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure South Africa PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure South Africa PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Israel PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Israel PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure Turkey PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure Turkey PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Figure GCC Countries PEGylated Proteins Consumption Growth 2013-2018 (g)
Figure GCC Countries PEGylated Proteins Value Growth 2013-2018 ($ Millions)
Table PEGylated Proteins Distributors List
Table PEGylated Proteins Customer List
Figure Global PEGylated Proteins Consumption Growth Rate Forecast (2018-2023) (g)
Figure Global PEGylated Proteins Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global PEGylated Proteins Consumption Forecast by Countries (2018-2023) (g)
Table Global PEGylated Proteins Consumption Market Forecast by Regions
Table Global PEGylated Proteins Value Forecast by Countries (2018-2023) ($ Millions)
Table Global PEGylated Proteins Value Market Share Forecast by Regions
Figure Americas PEGylated Proteins Consumption 2018-2023 (g)
Figure Americas PEGylated Proteins Value 2018-2023 ($ Millions)
Figure APAC PEGylated Proteins Consumption 2018-2023 (g)
Figure APAC PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Europe PEGylated Proteins Consumption 2018-2023 (g)
Figure Europe PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Middle East & Africa PEGylated Proteins Consumption 2018-2023 (g)
Figure Middle East & Africa PEGylated Proteins Value 2018-2023 ($ Millions)
Figure United States PEGylated Proteins Consumption 2018-2023 (g)
Figure United States PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Canada PEGylated Proteins Consumption 2018-2023 (g)
Figure Canada PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Mexico PEGylated Proteins Consumption 2018-2023 (g)
Figure Mexico PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Brazil PEGylated Proteins Consumption 2018-2023 (g)
Figure Brazil PEGylated Proteins Value 2018-2023 ($ Millions)
Figure China PEGylated Proteins Consumption 2018-2023 (g)
Figure China PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Japan PEGylated Proteins Consumption 2018-2023 (g)
Figure Japan PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Korea PEGylated Proteins Consumption 2018-2023 (g)
Figure Korea PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Southeast Asia PEGylated Proteins Consumption 2018-2023 (g)
Figure Southeast Asia PEGylated Proteins Value 2018-2023 ($ Millions)
Figure India PEGylated Proteins Consumption 2018-2023 (g)
Figure India PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Australia PEGylated Proteins Consumption 2018-2023 (g)
Figure Australia PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Germany PEGylated Proteins Consumption 2018-2023 (g)
Figure Germany PEGylated Proteins Value 2018-2023 ($ Millions)
Figure France PEGylated Proteins Consumption 2018-2023 (g)
Figure France PEGylated Proteins Value 2018-2023 ($ Millions)
Figure UK PEGylated Proteins Consumption 2018-2023 (g)
Figure UK PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Italy PEGylated Proteins Consumption 2018-2023 (g)
Figure Italy PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Russia PEGylated Proteins Consumption 2018-2023 (g)
Figure Russia PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Spain PEGylated Proteins Consumption 2018-2023 (g)
Figure Spain PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Egypt PEGylated Proteins Consumption 2018-2023 (g)
Figure Egypt PEGylated Proteins Value 2018-2023 ($ Millions)
Figure South Africa PEGylated Proteins Consumption 2018-2023 (g)
Figure South Africa PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Israel PEGylated Proteins Consumption 2018-2023 (g)
Figure Israel PEGylated Proteins Value 2018-2023 ($ Millions)
Figure Turkey PEGylated Proteins Consumption 2018-2023 (g)
Figure Turkey PEGylated Proteins Value 2018-2023 ($ Millions)
Figure GCC Countries PEGylated Proteins Consumption 2018-2023 (g)
Figure GCC Countries PEGylated Proteins Value 2018-2023 ($ Millions)
Table Global PEGylated Proteins Consumption Forecast by Type (2018-2023) (g)
Table Global PEGylated Proteins Consumption Market Share Forecast by Type (2018-2023)
Table Global PEGylated Proteins Value Forecast by Type (2018-2023) ($ Millions)
Table Global PEGylated Proteins Value Market Share Forecast by Type (2018-2023)
Table Global PEGylated Proteins Consumption Forecast by Application (2018-2023) (g)
Table Global PEGylated Proteins Consumption Market Share Forecast by Application (2018-2023)
Table Global PEGylated Proteins Value Forecast by Application (2018-2023) ($ Millions)
Table Global PEGylated Proteins Value Market Share Forecast by Application (2018-2023)
Table ENZON Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ENZON Pharmaceuticals PEGylated Proteins Market Share (2016-2018)
Table Merck Sharp & Dohme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Sharp & Dohme PEGylated Proteins Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche PEGylated Proteins Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer PEGylated Proteins Market Share (2016-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen PEGylated Proteins Market Share (2016-2018)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCB PEGylated Proteins Market Share (2016-2018)
Table Crealta (Savient) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Crealta (Savient) PEGylated Proteins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Crealta (Savient) PEGylated Proteins Market Share (2016-2018)
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs